Jilin Aodong Pharmaceutical Group Co., Ltd.

Shenzhen Stock Exchange:000623.SZ

Sector

🏥 Health Care

Industries

🧬 Biotechnology

💊 Pharmaceuticals

Location

China

Market Cap

USD 3.27 B

Share Price

USD 2.68

Avg Daily Volume

15,715,500

Change (1 day)

0.41%

Change (1 year)

42.50%

Change (YTD)

13.48%

Jilin Aodong Pharmaceutical Group Co., Ltd. EBIT Margin for the year ending December 31, 2024: 61.66%

Jilin Aodong Pharmaceutical Group Co., Ltd. EBIT Margin is 61.66% for the year ending December 31, 2024, a 29.78% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Jilin Aodong Pharmaceutical Group Co., Ltd. EBIT Margin for the year ending December 31, 2023 was 47.51%, a -26.69% change year over year.
Jilin Aodong Pharmaceutical Group Co., Ltd. EBIT Margin for the year ending December 31, 2022 was 64.81%, a -21.13% change year over year.
Jilin Aodong Pharmaceutical Group Co., Ltd. EBIT Margin for the year ending December 31, 2021 was 82.18%, a 0.59% change year over year.
Jilin Aodong Pharmaceutical Group Co., Ltd. EBIT Margin for the year ending December 31, 2020 was 81.69%, a 58.61% change year over year.